HSE to extend Soliris drug to PNH & aHUS patients – Deering
4th February 2015 - Fine Gael Press Office
Fine Gael Carlow/ Kilkenny TD, Pat Deering, has today (Wednesday) welcomed confirmation from the HSE that they are to extend access to the drug Eculizumab (trading as Soliris), for patients with the conditions Paroxysmal Nocturnal Hemoglobinuria (PNH) and atypical Haemolytic Uraemic (aHUS).
“I have been advocating for this drug to be State funded ever since I heard the story of Ballinakill woman Mary Gorman who has PNH, a very rare and debilitating disease.
Related news
Intel is not just a key employer but a key strategic international partner for Ireland - Neville
Everything must be done to ensure Intel remains in Leixlip and its production facilities are at the forefront of the…
25th April 2025Dublin footpaths and public spaces not fit for visually impaired residents – O’Connell
People with visual impairments are at risk of injury on many of Dublin’s footpaths and shared spaces, a Fine Gael…
25th April 2025Tánaiste announces Oireachtas Committee Chairpersons
An Tánaiste and Leader of Fine Gael Simon Harris TD has announced the appointment of the following Oireachtas Committee Chairpersons:…
24th April 2025